Triploid Breeding Process is Calyxt's Second Announced Advancement and Part of a Comprehensive Approach to Improving Hemp Genetics
ROSEVILLE, MN / ACCESSWIRE / July 8, 2021 / Calyxt, Inc. (NASDAQ:CLXT), today announced further expansion of its hemp breeding platform with the addition of triploid breeding technology to create seedless hemp.
Bringing this technology to hemp cultivation comes on the heels of the company announcing the successful transformation of the hemp genome. Together, these advancements demonstrate industry leadership in modernizing the crop.
"It's our mission at Calyxt to harness plants to generate valuable products" said Sarah Reiter, Chief Business Officer, Calyxt, Inc. "With our suite of innovations already announced and more still in development, hemp's potential as a system for production of healthy, plant-based protein, oil and alternatives to plastics is within our reach. Our goal is to enable easy access and use of our patent-pending triploid seed technology by partners across the industry in order to convert the potential benefits of hemp to reality as quickly as possible."
Like seedless watermelon, seedless hemp can offer significant advantages in crop management and harvest potential. For hemp fiber production, a seedless crop can improve fiber quality and increase yield. Grain production for hemp protein and oil derivatives can also be enhanced with a breeding program based on controlled pollination, effectively eliminating the threat of rogue pollinators that can suboptimize yields.
"Triploid hemp is an important step forward in modernizing the crop," said Travis Frey, Chief Technology Officer, Calyxt Inc. "From a breeding perspective, it's a foundational technology to rapidly unlock advancements in hemp genetics. The resulting seedless, pollen-proof plants offer growers significant upgrades for their cropping system by de-risking broad acre cultivation, likely improving both quality and yield."
Calyxt (NASDAQ:CLXT) is a technology company with a mission to deliver plant-based innovations for a better world. Founded in 2010, and based in Roseville, MN, Calyxt uses its proprietary TALEN® gene editing technology to work with world-class partners via technology licensing, product development, and seed sale arrangements to revolutionize the way the world uses plants to solve problems. For further information, please visit our website at www.calyxt.com.
This communication contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as "anticipates," "believes," "continue," "estimates," "expects," "targets," "intends," "may," "might," "plans," "potential," "predicts," "projects," "should," or "will," the negative of these terms and other similar terminology. Forward-looking statements in this press release include statements about our ideation and product development efforts, our business model and go-to-market strategies, and growth strategies.
These and other forward-looking statements are predictions and projections about future events and trends based on our current expectations, objectives and intentions and premised on current assumptions. Our actual results, level of activity, performance, or achievements could be materially different than those expressed, implied, or anticipated by forward-looking statements due to a variety of factors, including, but not limited to: the severity and duration of the evolving COVID-19 pandemic and the resulting impact on macro-economic conditions; the impact of increased competition; disruptions at our or our collaborators' key facilities; changes in customer preferences and market acceptance of our or our partners' products; competition for collaboration partners and licensees and the successful execution of collaborations and licensing agreements; the impact of adverse events during development; the impact of improper handling of our product candidates by unaffiliated third parties during development; failures by third-party contractors; inaccurate demand forecasting; the effectiveness of commercialization efforts by commercial partners or licensees; our ability to collect accounts receivable; commodity price conditions; the impact of changes or increases in oversight and regulation; disputes or challenges regarding intellectual property; proliferation and continuous evolution of new technologies; management changes; dislocations in the capital markets; and other important factors discussed under the caption entitled "Risk Factors" in our most recent Annual Report on Form 10-K and subsequent filings on Form 10-Q or 8-K with the U.S. Securities and Exchange Commission.
Any forward-looking statements made by us are based only on information currently available to us when, and speaks only as of the date, such statement is made. Except as otherwise required by securities and other applicable laws we do not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change.
For further information, please contact:
Calyxt Media Contact:
Calyxt Investor Relations Contacts: